Publication:
Treatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503).

Simple item page
dc.contributor.authorsGorevic, PD; Hawkins, PN; Butrimiene, I; Lesnyak, O; Livneh, A; Filipowicz-Sosnowska, A; Merlini, G; Direskeneli, H; Benson, MD; Dispenzieri, A; Gul, A; Hazenberg, BPC; Wiland, P; Obici, L; Lachmann, H; Briand, R; Garceau, D; Hauck, W; Dember, LM; Skinner, M
dc.date.accessioned2022-03-12T15:59:41Z
dc.date.accessioned2026-01-10T17:45:06Z
dc.date.available2022-03-12T15:59:41Z
dc.date.issued2005
dc.identifier.doidoiWOS:000234131500186
dc.identifier.issn0004-3591
dc.identifier.urihttps://hdl.handle.net/11424/224482
dc.identifier.wosWOS:000234131500186
dc.language.isoeng
dc.publisherWILEY-LISS
dc.relation.ispartofARTHRITIS AND RHEUMATISM
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleTreatment of AA amyloidosis: Results of a multi-center, randomized, placebo-controlled trial with 1,3-propanedisulfonate (1,3-PDS; NC-503).
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage4109
oaire.citation.issue12
oaire.citation.startPage4108
oaire.citation.titleARTHRITIS AND RHEUMATISM
oaire.citation.volume52

Files

Collections

Araştırma Çıktıları